An Ozempic successor falls short, Eli Lilly's GLP-1 pill, and senators grill RFK: Pharma news roundupByBruce GilPublishedMarch 14, 2025
Hims & Hers, Zealand, and Roche fall: Why weight loss drug stocks are down todayByBruce GilUpdatedMarch 13, 2025
Lawmakers demand answers from RFK Jr. over Trump dinners with pharma execsByBruce GilPublishedMarch 11, 2025
Viking Therapeutics closer to bringing its Ozempic competitor to marketByBruce GilUpdatedMarch 11, 2025
Eli Lilly's first weight loss pill could expand access to GLP-1s around the globe, executive saysByBruce GilPublishedMarch 10, 2025
Tesla's stock wipeout has hit Elon Musk's net worth by more than $150 billion this yearByBruce GilUpdatedMarch 7, 2025
